The global cell cytometry market is anticipated to grow at a CAGR of ~10%, till 2035, claims Roots Analysis
In order to accommodate the growing demand for higher accuracy, greater resolution and improved sensitivity in analytical processes, various industry stakeholders are engaged in the development of novel cytometry platforms with advanced features.
Roots Analysis has announced the addition of “Global Cell Cytometry Market: Focus on High Throughput Flow Cytometry and Image Cytometry, 2022-2035” report to its list of offerings.
Novel cell cytometry platforms has emerged to be the crucial analytical and visualization tools with applications across various areas, such as immunology, molecular biology, cancer biology and infectious disease monitoring. As a result, developers are currently engaged in the development of technologically advanced cell cytometry platforms that offer better throughput and accuracy.
Key Market Insights
Currently, more than 180 high throughput flow cytometry and image cytometry platforms are available in the market
Majority (92%) of the high throughput flow cytometers are cell analyzers. Of these, ~40% of the devices operate at a throughput rate of 4 to 15 wells per minute. Similarly, majority (~50%) of the image cytometers can operate as both cell analyzers and cell sorters. Of these, 90% of the devices offer qualitative analysis.
Presently, more than 25 developers are engaged in the development of cell cytometers, globally
Notably, around 40% of the developers that offer high throughput flow cytometers are very large players (having more than 5,000 employees). In addition, 45% of the image cytometer developers were established post 2000. Of these, 75% of the players are headquartered in North America.
Partnership activity in the global cell cytometry market has increased at steady rate, between 2017 and 2021
The maximum number of partnerships were established in 2021. Majority of the instances captured in the report were acquisitions and distribution agreements (25%, each). In addition, 75% of the deals have been inked by players headquartered in North America.
180+ USD million has been invested by various private and public investors in this domain, since 2017
Specifically, in 2020, the players raised over USD 125 million. It is worth noting that, majority (around 75%) of the investments were made in the form of venture capital rounds. Interestingly, around 45%of the funding instances were reported by mid-sized players (51 to 500 employees).
Close to 35 global events related to cell cytometry have been organized, since 2018
Majority of the global events related to cell cytometry include webinars (over 40%) and conferences (~35%). It is worth highlighting that the main agenda of these events was to discuss the advantages of novel cell cytometers and their potential applications.
~500 patents have been granted / filed for cell cytometers, since 2020
70% of these were patent applications; Of these, close to 50% of the patents have been filed in 2021. It is worth noting that 45% of the patents related to cell cytometry were filed / granted in China alone, followed by US (~30%).
The overall market is anticipated to grow at a CAGR of ~10%, during the period 2022-2035
North America and Europe are anticipated to capture around 35% of the market share, by 2035. In terms of types of cytometers, the image cytometers are expected to occupy a larger share (more than 55%) of the overall market in 2035.
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/....reports/cell-cytomet
Key Questions Answered
Who are the leading players engaged in the development of high throughput flow cytometers and image cytometers?
Which are the popular types of cytometers available in the market?
Which partnership models are commonly adopted by stakeholders engaged in this industry?
What are the investment trends and who are the key investors actively engaged in the development and commercialization of cell cytometers?
What are the key agenda items being discussed in various global events / conferences held related to cell cytometry platforms?
How is the current and future market opportunity likely to be distributed across key market segments?
The financial opportunity within the cell cytometry market has been analyzed across the following segments:
Type of Cytometer
High Throughput Flow Cytometer
Image Cytometer
Company Size
Very Small
Small
Mid-sized
Large
Very Large
Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World
The research also includes detailed profiles of key players (listed below) engaged in the cell cytometry market; each profile features an overview of the company, recent developments, and an informed future outlook.
Agilent
Beckman Coulter Life Sciences
Becton Dickinson
Bio-Rad
Chemotec
Milkotronic
Nexcelom Bioscinces
Sartorius
Sony Biotechnology
Thermo Fischer Scientific
Union Biometrica
For additional details, please visit https://www.rootsanalysis.com/....reports/cell-cytomet or email sales@rootsanalysis.com
You may also be interested in the following titles:
1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035
2. AI-based Digital Pathology / AI Pathology Market: Industry Trends and Global Forecasts, 2022-2035
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
